Characteristic | Lung Cancer Cases (N = 224) | Cancer-free Controls (N = 107) | P | ||
---|---|---|---|---|---|
Age, y | Â | Â | Â | Â | Â |
   Median (Range) | 68 (40-85) | 52 (31-83) | < 0.001†| ||
Sex, N % | Â | Â | Â | Â | Â |
   Male | 105 | 46.9% | 60 | 56.1% | 0.12‡ |
   Female | 119 | 53.1% | 47 | 43.9% |  |
Ethnicity, N % | Â | Â | Â | Â | Â |
   Caucasian | 212 | 95.5% | 101 | 94.4% | 0.70§ |
   African-American | 9 | 4.1% | 5 | 4.7% |  |
   Other | 1 | 0.5% | 1 | 0.9% |  |
Smoking Status, N % | Â | Â | Â | Â | Â |
   Never smoker | 19 | 8.5% | 33 | 30.8% | < 0.001‡ |
   Ex-smoker | 111 | 49.6% | 57 | 53.3% |  |
   Active smoker | 87 | 38.8% | 14 | 13.1% |  |
   Unknown | 7 | 3.1% | 3 | 2.8% |  |
Pack-Years | Â | Â | Â | Â | Â |
   Median (Range) | 50 (0-150) | 25 (0-156) | < 0.001†| ||
   Unknown | 0-150 | 0-156 |  | ||
Lung Function, N % | Â | Â | Â | Â | Â |
   Normal | 89 | 39.7% | 36 | 33.6% | < 0.001§ |
   Mild Obstruction | 14 | 6.3% | 5 | 4.7% |  |
   Moderate Obstruction | 52 | 23.2% | 16 | 15.0% |  |
   Severe Obstruction | 37 | 16.5% | 46 | 43.0% |  |
   Unknown | 32 | 14.3% | 4 | 3.7 |  |
Tumor Type, N % | Â | Â | Â | Â | Â |
   Adenocarcinoma | 112 | 50.0% | - |  |  |
   Squamous cell carcinoma | 60 | 26.8% | - |  |  |
   Other NSCLC | 27 | 12.1% | - |  |  |
   Small cell lung cancer | 10 | 4.5% | - |  |  |
   Other/unknown | 15 | 6.7% | - |  |  |
Stage, N % | Â | Â | Â | Â | Â |
   TIS-I | 99 | 44.2% | - |  |  |
   II | 38 | 17.0% | - |  |  |
   III | 49 | 21.9% | - |  |  |
   IV | 16 | 7.1% | - |  |  |
   Not Staged | 22 | 9.8% | - |  |  |
Follow-up, N % | Â | Â | Â | Â | Â |
   Alive | 78 | 34.8% | - |  |  |
   Dead | 142 | 63.4% | - |  |  |
   Median survival, months# | 35.8 | - |  |  | |
   (95% CI) | (31.7-40.5) | - |  |  |